Drug Side Effects

CYANOCOBALAMIN

CYANOCOBALAMIN was reported 31936 times

CYANOCOBALAMIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 37 0.3895
1 HEPATIC ENZYME 47 0.3588
2 NEUROLOGIC NEGLECT SYNDROME 181 0.3358
3 EJECTION FRACTION 163 0.2845
4 SENSITISATION 205 0.2730
5 HYPOCHOLESTEROLAEMIA 61 0.2421
6 CAROTID ARTERY THROMBOSIS 179 0.2164
7 PROLONGED EXPIRATION 38 0.1473
8 ADJUSTMENT DISORDER 184 0.1452
9 POLYCYSTIC OVARIES 207 0.1343
10 LUPUS VULGARIS 131 0.1216
11 GRANULOMA SKIN 98 0.1204
12 C-REACTIVE PROTEIN 98 0.1132
13 GAIT SPASTIC 33 0.0965
14 FACET JOINT SYNDROME 257 0.0877
15 PERSONALITY DISORDER 185 0.0719
16 MULTIPLE DRUG THERAPY 46 0.0706
17 BLOOD PARATHYROID HORMONE DECREASED 101 0.0689
18 NEEDLE FATIGUE 30 0.0668
19 DEEP VEIN THROMBOSIS POSTOPERATIVE 120 0.0648
20 EJECTION FRACTION ABNORMAL 75 0.0622
21 PERNICIOUS ANAEMIA 36 0.0595
22 RHEUMATOID FACTOR POSITIVE 329 0.0589
23 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 38 0.0581
24 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 29 0.0573
25 SWOLLEN JOINT COUNT INCREASED 169 0.0573
26 RHINITIS ALLERGIC 233 0.0542
27 OBSTRUCTIVE SLEEP APNOEA SYNDROME 70 0.0540
28 CLOSTRIDIUM TEST POSITIVE 111 0.0529
29 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 92 0.0487
30 PERIPHERAL VENOUS DISEASE 182 0.0481
31 DUODENAL ULCER PERFORATION 320 0.0457
32 RHEUMATIC FEVER 189 0.0456
33 DRUG TOLERANCE DECREASED 123 0.0453
34 RELAPSING-REMITTING MULTIPLE SCLEROSIS 38 0.0450
35 PANNICULITIS 102 0.0435
36 DISLOCATION OF VERTEBRA 90 0.0434
37 NEPHRECTOMY 61 0.0423
38 MUSCLE INJURY 327 0.0417
39 SKIN NEOPLASM EXCISION 31 0.0407
40 RHEUMATOID NODULE 110 0.0402
41 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 270 0.0396
42 X-RAY ABNORMAL 64 0.0373
43 BLEPHAROSPASM 212 0.0359
44 BREAST CANCER STAGE III 222 0.0359
45 HELICOBACTER INFECTION 345 0.0353
46 LIP DRY 295 0.0344
47 PEMPHIGUS 401 0.0336
48 VITAMIN B12 DEFICIENCY 128 0.0332
49 BREATH SOUNDS ABNORMAL 155 0.0324
50 FOLLICULITIS 296 0.0300
51 PORPHYRIA ACUTE 38 0.0294
52 ULCER HAEMORRHAGE 187 0.0283
53 SYNOVITIS 496 0.0283
54 VITAMIN B12 DECREASED 78 0.0281
55 NAIL DISORDER 233 0.0278
56 SENSORY LOSS 214 0.0272
57 C-REACTIVE PROTEIN ABNORMAL 165 0.0268
58 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 163 0.0263
59 FIBROMYALGIA 612 0.0260
60 HAND DEFORMITY 327 0.0259
61 LUMBAR RADICULOPATHY 29 0.0254
62 WOUND INFECTION 261 0.0250
63 HEMIPLEGIA 200 0.0246
64 HYPERCHOLESTEROLAEMIA 226 0.0245
65 NEOPLASM SKIN 37 0.0243
66 EYE INJURY 69 0.0237
67 MOTOR DYSFUNCTION 229 0.0233
68 BURSITIS 270 0.0232
69 PERICARDITIS 370 0.0231
70 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 345 0.0231
71 GANGRENE 132 0.0223
72 JOINT RANGE OF MOTION DECREASED 287 0.0222
73 SLEEP APNOEA SYNDROME 413 0.0221
74 CARPAL TUNNEL SYNDROME 298 0.0218
75 AFFECT LABILITY 205 0.0217
76 HYPERPARATHYROIDISM SECONDARY 53 0.0214
77 MUSCLE SPASTICITY 252 0.0207
78 SKIN NECROSIS 105 0.0206
79 RED BLOOD CELL SEDIMENTATION RATE INCREASED 223 0.0206
80 NEPHROGENIC ANAEMIA 94 0.0205
81 BLOOD TEST ABNORMAL 272 0.0199
82 INFUSION SITE REACTION 52 0.0189
83 IRRITABLE BOWEL SYNDROME 390 0.0189
84 WHITE BLOOD CELLS URINE POSITIVE 34 0.0187
85 INTRAMEDULLARY ROD INSERTION 38 0.0185
86 MONOPARESIS 33 0.0185
87 HYPERTONIC BLADDER 51 0.0182
88 RETINITIS 28 0.0181
89 PULMONARY FIBROSIS 335 0.0181
90 ARTERIAL OCCLUSIVE DISEASE 135 0.0175
91 BONE EROSION 60 0.0175
92 LIVE BIRTH 136 0.0170
93 OBESITY 262 0.0169
94 COORDINATION ABNORMAL 227 0.0165
95 APPETITE DISORDER 98 0.0159
96 GLOSSODYNIA 341 0.0157
97 PNEUMONIA VIRAL 48 0.0156
98 LIVER INJURY 360 0.0155
99 TASTE DISORDER 282 0.0147
100 PRODUCT ADMINISTRATION INTERRUPTED 108 0.0146
101 REBOUND ACID HYPERSECRETION 44 0.0145
102 PRE-EXISTING CONDITION IMPROVED 90 0.0145
103 ONYCHOMADESIS 57 0.0144
104 SINUS CONGESTION 184 0.0140
105 HEMIPARESIS 231 0.0139
106 TYPE 2 DIABETES MELLITUS 452 0.0138
107 PRESCRIBED UNDERDOSE 265 0.0137
108 SCIATICA 209 0.0136
109 IRON DEFICIENCY 58 0.0136
110 BLOOD PRESSURE SYSTOLIC ABNORMAL 33 0.0136
111 DRUG TOLERANCE 66 0.0134
112 WOUND 359 0.0133
113 INFREQUENT BOWEL MOVEMENTS 32 0.0133
114 ESSENTIAL HYPERTENSION 33 0.0132
115 PNEUMONIA ASPIRATION 317 0.0131
116 WHEEZING 744 0.0130
117 VITAMIN D DEFICIENCY 120 0.0127
118 AUTOIMMUNE DISORDER 116 0.0127
119 C-REACTIVE PROTEIN INCREASED 448 0.0127
120 GASTROOESOPHAGEAL REFLUX DISEASE 980 0.0126
121 OSTEOARTHRITIS 518 0.0125
122 EATING DISORDER 259 0.0124
123 RED CELL DISTRIBUTION WIDTH INCREASED 50 0.0124
124 BLOOD PRESSURE DIASTOLIC ABNORMAL 31 0.0123
125 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 557 0.0122
126 PSORIATIC ARTHROPATHY 466 0.0120
127 HYPERCALCAEMIA 144 0.0120
128 BLOOD PRESSURE INADEQUATELY CONTROLLED 70 0.0119
129 SKIN HAEMORRHAGE 162 0.0118
130 IMPAIRED HEALING 377 0.0118
131 DEPRESSIVE SYMPTOM 40 0.0117
132 MEAN CELL VOLUME INCREASED 29 0.0117
133 EXERCISE TOLERANCE DECREASED 64 0.0116
134 URINE ANALYSIS ABNORMAL 34 0.0116
135 LOWER RESPIRATORY TRACT INFECTION 501 0.0115
136 INFUSION RELATED REACTION 734 0.0115
137 GRIP STRENGTH DECREASED 97 0.0115
138 OBSTRUCTION 44 0.0113
139 SINUS DISORDER 218 0.0113
140 EXOSTOSIS 98 0.0111
141 REGURGITATION 36 0.0110
142 SMALL INTESTINAL OBSTRUCTION 130 0.0109
143 BLOOD MAGNESIUM DECREASED 91 0.0108
144 RESPIRATORY TRACT CONGESTION 166 0.0108
145 ARTHROPATHY 579 0.0107
146 NIGHT SWEATS 332 0.0106
147 PRESCRIBED OVERDOSE 200 0.0106
148 HYPOTHYROIDISM 327 0.0106
149 IRON DEFICIENCY ANAEMIA 94 0.0106
150 BLOOD CREATININE DECREASED 32 0.0106
151 LUMBAR SPINAL STENOSIS 30 0.0105
152 EMBOLIC STROKE 36 0.0105
153 BASAL CELL CARCINOMA 159 0.0105
154 CONTRAINDICATED PRODUCT ADMINISTERED 301 0.0103
155 LOWER LIMB FRACTURE 189 0.0103
156 VASCULAR DEVICE INFECTION 44 0.0102
157 NOCTURIA 119 0.0101
158 INTERVERTEBRAL DISC DEGENERATION 92 0.0101
159 INFLAMMATION 501 0.0101
160 VIRAL UPPER RESPIRATORY TRACT INFECTION 47 0.0100
161 FULL BLOOD COUNT ABNORMAL 100 0.0098
162 BACK INJURY 102 0.0097
163 DYSARTHRIA 353 0.0096
164 BLOOD IRON DECREASED 109 0.0096
165 PUSTULAR PSORIASIS 32 0.0095
166 HYPERTRANSAMINASAEMIA 61 0.0095
167 RESPIRATION ABNORMAL 62 0.0094
168 SNEEZING 204 0.0094
169 CYSTITIS 294 0.0094
170 CHRONIC SINUSITIS 34 0.0093
171 STOMATITIS 545 0.0092
172 FREEZING PHENOMENON 31 0.0091
173 BREAST CANCER STAGE II 74 0.0090
174 RALES 51 0.0090
175 BLOOD ALBUMIN DECREASED 69 0.0090
176 EPILEPSY 264 0.0089
177 CARDIAC MURMUR 75 0.0088
178 APHASIA 259 0.0088
179 LOW TURNOVER OSTEOPATHY 35 0.0088
180 SPINAL OSTEOARTHRITIS 75 0.0087
181 FLANK PAIN 79 0.0087
182 TRIGEMINAL NEURALGIA 34 0.0087
183 HAEMORRHAGIC ANAEMIA 38 0.0086
184 DIVERTICULUM INTESTINAL 36 0.0086
185 URINE ABNORMALITY 37 0.0086
186 ULCER 133 0.0086
187 INCREASED TENDENCY TO BRUISE 77 0.0085
188 SINUSITIS 847 0.0085
189 RHEUMATOID ARTHRITIS 928 0.0085
190 HEPATIC ENZYME INCREASED 555 0.0084
191 THERAPEUTIC PRODUCT EFFECT DECREASED 356 0.0083
192 OSTEOPENIA 123 0.0083
193 ARTHRITIS 631 0.0082
194 ANGINA PECTORIS 231 0.0082
195 RENAL DISORDER 371 0.0082
196 SYNOVIAL CYST 37 0.0081
197 GAIT INABILITY 259 0.0081
198 DENTAL CARIES 87 0.0081
199 HUMERUS FRACTURE 38 0.0081
200 HYSTERECTOMY 67 0.0080
201 BLOOD PRESSURE FLUCTUATION 188 0.0080
202 BLOOD CHOLESTEROL INCREASED 363 0.0080
203 SPINAL FUSION SURGERY 31 0.0080
204 SPONDYLITIS 28 0.0079
205 INTENTIONAL PRODUCT USE ISSUE 678 0.0079
206 WALKING AID USER 51 0.0079
207 BOWEL MOVEMENT IRREGULARITY 58 0.0079
208 SNORING 29 0.0079
209 LUPUS-LIKE SYNDROME 69 0.0079
210 PROTEIN URINE PRESENT 38 0.0079
211 BLOOD PRESSURE SYSTOLIC INCREASED 150 0.0079
212 BONE DENSITY ABNORMAL 29 0.0078
213 MICTURITION URGENCY 86 0.0078
214 EAR PAIN 148 0.0078
215 SKIN ULCER 196 0.0078
216 END STAGE RENAL DISEASE 141 0.0078
217 SEASONAL ALLERGY 105 0.0078
218 BENIGN PROSTATIC HYPERPLASIA 39 0.0077
219 OEDEMA 405 0.0077
220 JOINT SWELLING 897 0.0077
221 ASTHMA 828 0.0077
222 MOBILITY DECREASED 525 0.0076
223 DRUG ERUPTION 129 0.0076
224 ONYCHOMYCOSIS 32 0.0075
225 DRUG LEVEL ABOVE THERAPEUTIC 33 0.0075
226 POOR VENOUS ACCESS 75 0.0075
227 HYPOPHOSPHATAEMIA 53 0.0075
228 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 119 0.0075
229 APHTHOUS ULCER 55 0.0075
230 MUSCULOSKELETAL PAIN 379 0.0073
231 DRUG INTOLERANCE 681 0.0073
232 ANAL INCONTINENCE 62 0.0073
233 OROPHARYNGEAL DISCOMFORT 62 0.0072
234 HEPATITIS 180 0.0072
235 LUNG DISORDER 341 0.0072
236 MIGRAINE 654 0.0071
237 WHEELCHAIR USER 31 0.0071
238 ENURESIS 28 0.0071
239 SKIN ABRASION 32 0.0071
240 HYPERVOLAEMIA 32 0.0071
241 NEPHROPATHY 65 0.0071
242 RASH VESICULAR 33 0.0071
243 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 484 0.0071
244 LARYNGITIS 74 0.0070
245 ON AND OFF PHENOMENON 34 0.0070
246 BLISTER 380 0.0070
247 HAEMATOCRIT DECREASED 136 0.0070
248 ATAXIA 80 0.0069
249 NECK PAIN 374 0.0069
250 IMPAIRED GASTRIC EMPTYING 78 0.0068
251 UPPER RESPIRATORY TRACT INFECTION 304 0.0068
252 HYPERTENSION 1399 0.0068
253 PULMONARY FUNCTION TEST DECREASED 29 0.0068
254 SLEEP DISORDER 455 0.0067
255 DYSLIPIDAEMIA 33 0.0067
256 LIVER DISORDER 287 0.0067
257 ATELECTASIS 63 0.0067
258 INFUSION SITE ERYTHEMA 53 0.0067
259 DRUG LEVEL BELOW THERAPEUTIC 35 0.0066
260 HYPERLIPIDAEMIA 77 0.0066
261 SCRATCH 65 0.0066
262 BODY TEMPERATURE DECREASED 64 0.0066
263 ANAL FISSURE 34 0.0066
264 LYMPHOCYTE COUNT DECREASED 113 0.0065
265 SQUAMOUS CELL CARCINOMA OF SKIN 38 0.0065
266 PERONEAL NERVE PALSY 36 0.0065
267 POLYP 41 0.0064
268 CHRONIC KIDNEY DISEASE 483 0.0064
269 PERIPHERAL SWELLING 948 0.0064
270 SWELLING 577 0.0064
271 DISCOMFORT 372 0.0064
272 JOINT EFFUSION 43 0.0064
273 BACK DISORDER 101 0.0064
274 HYPOAESTHESIA 926 0.0063
275 HIATUS HERNIA 80 0.0063
276 PULMONARY MASS 91 0.0063
277 INJURY 434 0.0063
278 VITAMIN D DECREASED 52 0.0063
279 MUSCULAR WEAKNESS 689 0.0062
280 INFUSION SITE PAIN 77 0.0062
281 STRESS FRACTURE 33 0.0062
282 GASTROINTESTINAL DISORDER 524 0.0062
283 BLOOD PRESSURE DIASTOLIC INCREASED 28 0.0062
284 RASH PRURITIC 322 0.0062
285 DECUBITUS ULCER 49 0.0062
286 RHINORRHOEA 384 0.0062
287 FEMUR FRACTURE 185 0.0061
288 CYST 74 0.0061
289 FAILURE TO THRIVE 31 0.0061
290 TENDERNESS 62 0.0061
291 INFUSION SITE SWELLING 36 0.0061
292 DIABETES MELLITUS INADEQUATE CONTROL 104 0.0061
293 MULTIPLE ALLERGIES 46 0.0061
294 RIGHT VENTRICULAR FAILURE 42 0.0061
295 TROPONIN INCREASED 44 0.0061
296 TRANSFUSION 62 0.0061
297 CONTUSION 564 0.0060
298 PRODUCTIVE COUGH 275 0.0060
299 CONFUSIONAL STATE 951 0.0060
300 ABDOMINAL TENDERNESS 29 0.0060
301 COMA 279 0.0060
302 POST-TRAUMATIC STRESS DISORDER 39 0.0060
303 EAR INFECTION 153 0.0059
304 BLOOD URIC ACID INCREASED 33 0.0059
305 ASPARTATE AMINOTRANSFERASE INCREASED 305 0.0059
306 ADRENAL INSUFFICIENCY 68 0.0059
307 WEIGHT FLUCTUATION 59 0.0059
308 ACUTE RESPIRATORY FAILURE 109 0.0059
309 MUSCULOSKELETAL STIFFNESS 500 0.0059
310 CATARACT 336 0.0059
311 LYMPHOEDEMA 39 0.0058
312 UPPER-AIRWAY COUGH SYNDROME 46 0.0058
313 NASOPHARYNGITIS 1040 0.0058
314 ROAD TRAFFIC ACCIDENT 235 0.0058
315 HEAD DISCOMFORT 98 0.0058
316 BURNING SENSATION 393 0.0058
317 GLAUCOMA 108 0.0058
318 SOMNAMBULISM 37 0.0058
319 DELIRIUM 193 0.0058
320 RHINITIS 45 0.0057
321 EOSINOPHILIA 97 0.0057
322 POLYARTHRITIS 29 0.0057
323 MALNUTRITION 61 0.0057
324 SKIN WARM 32 0.0057
325 RED BLOOD CELL COUNT DECREASED 157 0.0056
326 ALANINE AMINOTRANSFERASE INCREASED 336 0.0056
327 INFUSION SITE EXTRAVASATION 34 0.0056
328 CARDIOMEGALY 68 0.0056
329 DECREASED ACTIVITY 58 0.0056
330 DRY MOUTH 436 0.0056
331 ATRIAL FLUTTER 43 0.0055
332 NEPHROLITHIASIS 244 0.0055
333 URINARY INCONTINENCE 159 0.0055
334 HEART RATE DECREASED 189 0.0055
335 NEURALGIA 129 0.0055
336 GENERAL PHYSICAL HEALTH DETERIORATION 608 0.0055
337 SCOLIOSIS 33 0.0055
338 HIP ARTHROPLASTY 80 0.0055
339 BACTERAEMIA 62 0.0055
340 LIGAMENT SPRAIN 52 0.0054
341 DYSPNOEA EXERTIONAL 197 0.0054
342 RENAL CYST 42 0.0054
343 DYSPHAGIA 497 0.0054
344 BLOOD PRESSURE INCREASED 806 0.0054
345 GLOMERULAR FILTRATION RATE DECREASED 63 0.0054
346 URINE ODOUR ABNORMAL 31 0.0054
347 BLOOD PRESSURE DIASTOLIC DECREASED 39 0.0054
348 FOOT DEFORMITY 58 0.0054
349 TUBULOINTERSTITIAL NEPHRITIS 97 0.0054
350 RESPIRATORY TRACT INFECTION 134 0.0053
351 CENTRAL NERVOUS SYSTEM LESION 72 0.0053
352 MYOSITIS 46 0.0053
353 NORMAL NEWBORN 28 0.0053
354 MITRAL VALVE INCOMPETENCE 58 0.0053
355 ACUTE KIDNEY INJURY 776 0.0053
356 ORAL CANDIDIASIS 66 0.0053
357 THERAPY NON-RESPONDER 225 0.0053
358 FOOD ALLERGY 38 0.0052
359 OSTEOPOROSIS 210 0.0052
360 URINARY TRACT INFECTION 865 0.0052
361 ARTERIOSCLEROSIS 48 0.0052
362 JOINT DISLOCATION 53 0.0052
363 BRADYKINESIA 29 0.0052
364 ARTHROPOD BITE 37 0.0052
365 BLOOD CALCIUM DECREASED 57 0.0052
366 ORAL DISORDER 37 0.0052
367 FALL 1668 0.0052
368 GINGIVAL PAIN 40 0.0052
369 TOOTH DISORDER 112 0.0051
370 BLOOD POTASSIUM DECREASED 150 0.0051
371 TOOTH ABSCESS 51 0.0051
372 INTERVERTEBRAL DISC PROTRUSION 109 0.0051
373 ORTHOSTATIC HYPOTENSION 86 0.0051
374 DIVERTICULUM 36 0.0051
375 CLOSTRIDIUM DIFFICILE COLITIS 52 0.0051
376 CONCUSSION 38 0.0051
377 POSTOPERATIVE WOUND INFECTION 33 0.0050
378 CHEST DISCOMFORT 498 0.0050
379 PELVIC FRACTURE 38 0.0050
380 NEUTROPENIC SEPSIS 35 0.0050
381 TENDONITIS 76 0.0050
382 FEBRILE NEUTROPENIA 320 0.0050
383 BLOOD UREA INCREASED 82 0.0050
384 LIVER FUNCTION TEST INCREASED 102 0.0050
385 INSURANCE ISSUE 68 0.0050
386 RIB FRACTURE 99 0.0050
387 HYPOKALAEMIA 221 0.0050
388 RESTLESS LEGS SYNDROME 88 0.0050
389 BRAIN FOG 65 0.0049
390 CARDIAC FLUTTER 31 0.0049
391 ABDOMINAL DISCOMFORT 798 0.0049
392 ESCHERICHIA INFECTION 39 0.0049
393 DEFAECATION URGENCY 33 0.0049
394 FRUSTRATION TOLERANCE DECREASED 38 0.0049
395 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 43 0.0049
396 BALANCE DISORDER 412 0.0049
397 PERICARDIAL EFFUSION 109 0.0049
398 ASPIRATION 51 0.0049
399 HEPATIC CIRRHOSIS 88 0.0049
400 MEMORY IMPAIRMENT 649 0.0048
401 DYSPEPSIA 460 0.0048
402 COVID-19 PNEUMONIA 56 0.0048
403 SPINAL COMPRESSION FRACTURE 40 0.0048
404 LOWER GASTROINTESTINAL HAEMORRHAGE 35 0.0048
405 UPPER GASTROINTESTINAL HAEMORRHAGE 79 0.0048
406 ABDOMINAL PAIN 1083 0.0048
407 ANAEMIA 892 0.0048
408 ELECTROCARDIOGRAM ABNORMAL 37 0.0048
409 OEDEMA PERIPHERAL 572 0.0048
410 MAJOR DEPRESSION 34 0.0048
411 MASS 65 0.0048
412 HYPOMAGNESAEMIA 64 0.0048
413 MUSCLE STRAIN 40 0.0048
414 INTENTIONAL DOSE OMISSION 121 0.0048
415 GASTROENTERITIS 67 0.0047
416 TOOTH FRACTURE 51 0.0047
417 APHONIA 64 0.0047
418 THERAPEUTIC RESPONSE DECREASED 276 0.0047
419 HEPATIC STEATOSIS 85 0.0047
420 POST PROCEDURAL INFECTION 37 0.0047
421 NASAL CONGESTION 267 0.0047
422 POLLAKIURIA 190 0.0047
423 GASTRITIS 120 0.0047
424 ASTHENIA 1708 0.0047
425 TREATMENT FAILURE 369 0.0047
426 PRESYNCOPE 109 0.0047
427 DEHYDRATION 603 0.0047
428 OXYGEN SATURATION DECREASED 250 0.0046
429 PRODUCT DISTRIBUTION ISSUE 38 0.0046
430 BLOOD POTASSIUM INCREASED 73 0.0046
431 CELLULITIS 227 0.0046
432 LARGE INTESTINE POLYP 31 0.0046
433 CONDITION AGGRAVATED 1342 0.0046
434 PNEUMONIA 1438 0.0046
435 NEUTROPHIL COUNT INCREASED 46 0.0046
436 MENTAL STATUS CHANGES 124 0.0046
437 INFLUENZA 496 0.0046
438 RENAL FAILURE CHRONIC 35 0.0045
439 BLADDER DISORDER 44 0.0045
440 RENAL TUBULAR NECROSIS 43 0.0045
441 KIDNEY INFECTION 86 0.0045
442 ARTERIOSCLEROSIS CORONARY ARTERY 29 0.0045
443 ILL-DEFINED DISORDER 266 0.0045
444 INTESTINAL OBSTRUCTION 162 0.0045
445 PROCTALGIA 28 0.0045
446 HAEMOGLOBIN DECREASED 449 0.0045
447 SQUAMOUS CELL CARCINOMA 41 0.0045
448 LUNG INFILTRATION 39 0.0045
449 ECCHYMOSIS 30 0.0045
450 SPUTUM DISCOLOURED 41 0.0045
451 DELUSION 67 0.0045
452 TEMPERATURE INTOLERANCE 44 0.0045
453 AMNESIA 282 0.0044
454 PNEUMONIA BACTERIAL 39 0.0044
455 SKIN LACERATION 46 0.0044
456 GOUT 77 0.0044
457 OBSTRUCTIVE AIRWAYS DISORDER 48 0.0044
458 HEAD INJURY 135 0.0044
459 HEPATIC CYTOLYSIS 50 0.0044
460 ADVERSE EVENT 394 0.0044
461 WEIGHT DECREASED 1189 0.0044
462 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 222 0.0044
463 DERMATITIS 87 0.0044
464 KNEE ARTHROPLASTY 88 0.0044
465 IMMUNODEFICIENCY 62 0.0044
466 STRESS 305 0.0044
467 POOR QUALITY SLEEP 90 0.0043
468 ELECTROLYTE IMBALANCE 48 0.0043
469 LOCALISED INFECTION 102 0.0043
470 PERIPHERAL COLDNESS 58 0.0043
471 ECONOMIC PROBLEM 66 0.0043
472 OESOPHAGITIS 46 0.0043
473 BRONCHITIS 314 0.0043
474 ABNORMAL LOSS OF WEIGHT 28 0.0043
475 FOOT FRACTURE 80 0.0043
476 JOINT STIFFNESS 110 0.0043
477 DECREASED APPETITE 964 0.0043
478 ALOPECIA 821 0.0043
479 GASTROENTERITIS VIRAL 75 0.0043
480 AORTIC ANEURYSM 32 0.0043
481 RESPIRATORY SYNCYTIAL VIRUS INFECTION 35 0.0043
482 HEART RATE IRREGULAR 95 0.0043
483 WEIGHT INCREASED 919 0.0043
484 FATIGUE 3217 0.0043
485 MYASTHENIA GRAVIS 32 0.0043
486 ARTHRALGIA 1709 0.0043
487 PLATELET COUNT INCREASED 54 0.0043
488 MATERNAL EXPOSURE DURING PREGNANCY 362 0.0043
489 MUSCLE SPASMS 756 0.0042
490 PYREXIA 1427 0.0042
491 DEPRESSED MOOD 216 0.0042
492 HYPOXIA 144 0.0042
493 DEPRESSION 944 0.0042
494 LIMB INJURY 111 0.0042
495 LEUKOCYTOSIS 74 0.0042
496 URINE OUTPUT DECREASED 36 0.0042
497 EOSINOPHIL COUNT INCREASED 34 0.0042
498 PARAESTHESIA 645 0.0042
499 TRICUSPID VALVE INCOMPETENCE 32 0.0042
500 MUSCULOSKELETAL CHEST PAIN 63 0.0042
501 JOINT INJURY 87 0.0042
502 WHITE BLOOD CELL COUNT INCREASED 157 0.0042
503 FULL BLOOD COUNT DECREASED 82 0.0042
504 DERMATITIS CONTACT 46 0.0042
505 BLOOD PRESSURE ABNORMAL 80 0.0042
506 BLOOD SODIUM DECREASED 76 0.0042
507 ABNORMAL FAECES 33 0.0042
508 URTICARIA 668 0.0042
509 BLOOD CREATININE INCREASED 265 0.0042
510 ATRIAL FIBRILLATION 393 0.0041
511 HALLUCINATION, VISUAL 84 0.0041
512 COGNITIVE DISORDER 186 0.0041
513 HAEMATURIA 138 0.0041
514 VISUAL FIELD DEFECT 29 0.0041
515 CANDIDA INFECTION 66 0.0041
516 ANKLE FRACTURE 62 0.0041
517 HAEMORRHOIDS 78 0.0041
518 CARDIAC DISORDER 375 0.0041
519 PHOTOPHOBIA 74 0.0041
520 ANXIETY 1132 0.0041
521 DIVERTICULITIS 109 0.0041
522 HALLUCINATION 295 0.0041
523 GENERAL SYMPTOM 30 0.0041
524 SKIN INFECTION 44 0.0041
525 NEUROPATHY PERIPHERAL 370 0.0041
526 GAIT DISTURBANCE 757 0.0040
527 RENAL IMPAIRMENT 328 0.0040
528 EYE INFECTION 44 0.0040
529 WRIST FRACTURE 47 0.0040
530 FAECES SOFT 28 0.0040
531 DISABILITY 77 0.0040
532 CHEST PAIN 726 0.0040
533 INSOMNIA 1043 0.0040
534 DIZZINESS POSTURAL 37 0.0040
535 HOSPICE CARE 38 0.0040
536 MOUTH ULCERATION 81 0.0040
537 RENAL INJURY 117 0.0040
538 ANHEDONIA 103 0.0040
539 TOOTH EXTRACTION 48 0.0040
540 IMPAIRED QUALITY OF LIFE 55 0.0039
541 UROSEPSIS 35 0.0039
542 CONSTIPATION 816 0.0039
543 SOMNOLENCE 764 0.0039
544 POLYURIA 31 0.0039
545 FUNGAL INFECTION 126 0.0039
546 ORAL PAIN 85 0.0039
547 SUPRAVENTRICULAR TACHYCARDIA 36 0.0039
548 FEEDING DISORDER 73 0.0039
549 BACK PAIN 871 0.0039
550 RECTAL HAEMORRHAGE 162 0.0039
551 FREQUENT BOWEL MOVEMENTS 100 0.0039
552 HYPERKALAEMIA 130 0.0038
553 VOMITING 1736 0.0038
554 CHOLECYSTECTOMY 42 0.0038
555 HYPERSOMNIA 106 0.0038
556 GASTROINTESTINAL INFECTION 33 0.0038
557 HEADACHE 2313 0.0038
558 HYPOPHAGIA 93 0.0038
559 INTERSTITIAL LUNG DISEASE 178 0.0038
560 RENAL FAILURE 497 0.0038
561 MOVEMENT DISORDER 119 0.0038
562 COVID-19 655 0.0038
563 INFECTION 528 0.0038
564 DYSURIA 135 0.0038
565 BLOOD PRESSURE DECREASED 242 0.0038
566 TOOTHACHE 66 0.0038
567 EMPHYSEMA 37 0.0037
568 ILLNESS 354 0.0037
569 ROTATOR CUFF SYNDROME 47 0.0037
570 LIMB DISCOMFORT 112 0.0037
571 MELAENA 80 0.0037
572 DYSPNOEA 2036 0.0037
573 ATRIOVENTRICULAR BLOCK 28 0.0037
574 PHARYNGITIS STREPTOCOCCAL 39 0.0037
575 ABDOMINAL PAIN UPPER 735 0.0037
576 NERVE COMPRESSION 33 0.0037
577 INCONTINENCE 38 0.0037
578 BLOOD URINE PRESENT 68 0.0037
579 GASTRIC ULCER 68 0.0037
580 OROPHARYNGEAL PAIN 329 0.0037
581 DRUG HYPERSENSITIVITY 694 0.0037
582 SPINAL OPERATION 42 0.0036
583 FLUID OVERLOAD 53 0.0036
584 DRUG-INDUCED LIVER INJURY 107 0.0036
585 LABORATORY TEST ABNORMAL 104 0.0036
586 PANCYTOPENIA 196 0.0036
587 SEPSIS 391 0.0036
588 PLATELET COUNT DECREASED 373 0.0036
589 TRANSIENT ISCHAEMIC ATTACK 119 0.0036
590 OPTIC NEURITIS 32 0.0036
591 BLOOD LACTATE DEHYDROGENASE INCREASED 56 0.0036
592 URINARY RETENTION 116 0.0036
593 CLOSTRIDIUM DIFFICILE INFECTION 75 0.0036
594 INTERNAL HAEMORRHAGE 40 0.0036
595 PAIN 2146 0.0036
596 MACULAR DEGENERATION 41 0.0035
597 ABDOMINAL DISTENSION 355 0.0035
598 HERPES ZOSTER 198 0.0035
599 INFLUENZA LIKE ILLNESS 285 0.0035
600 HIP FRACTURE 110 0.0035
601 FRACTURE 65 0.0035
602 PNEUMONITIS 92 0.0035
603 HYPERSENSITIVITY 630 0.0035
604 RESPIRATORY DISORDER 102 0.0035
605 PRODUCT USE ISSUE 630 0.0035
606 PETECHIAE 35 0.0035
607 HERNIA 65 0.0035
608 ABSCESS 54 0.0035
609 DIARRHOEA 2155 0.0035
610 DEAFNESS 88 0.0035
611 NAUSEA 2645 0.0035
612 PHARYNGITIS 42 0.0035
613 PALPITATIONS 391 0.0035
614 LEUKOPENIA 167 0.0034
615 HYPOCALCAEMIA 63 0.0034
616 COLITIS 125 0.0034
617 IMMUNE SYSTEM DISORDER 44 0.0034
618 LYMPHOPENIA 47 0.0034
619 SKIN CANCER 72 0.0034
620 PLEURAL EFFUSION 204 0.0034
621 MUSCLE TIGHTNESS 54 0.0034
622 SKIN EXFOLIATION 273 0.0034
623 FAECES DISCOLOURED 72 0.0034
624 FLUID RETENTION 169 0.0034
625 RENAL FAILURE ACUTE 145 0.0034
626 TREATMENT NONCOMPLIANCE 179 0.0034
627 HEREDITARY ANGIOEDEMA 34 0.0034
628 VIRAL INFECTION 109 0.0034
629 MUSCLE ATROPHY 41 0.0034
630 PAIN IN EXTREMITY 970 0.0034
631 ILEUS 40 0.0034
632 GASTROINTESTINAL HAEMORRHAGE 277 0.0034
633 SUBDURAL HAEMATOMA 47 0.0034
634 COELIAC DISEASE 32 0.0034
635 MUSCLE RIGIDITY 39 0.0034
636 FACIAL PAIN 29 0.0034
637 ORAL HERPES 63 0.0033
638 HYPOAESTHESIA ORAL 49 0.0033
639 ENCEPHALOPATHY 79 0.0033
640 PULMONARY HYPERTENSION 68 0.0033
641 EAR DISCOMFORT 33 0.0033
642 NEUTROPHIL COUNT DECREASED 130 0.0033
643 WHITE BLOOD CELL COUNT DECREASED 350 0.0033
644 HAEMATEMESIS 82 0.0033
645 HEART RATE INCREASED 316 0.0033
646 DIZZINESS 1591 0.0033
647 OSTEOMYELITIS 58 0.0033
648 UPPER LIMB FRACTURE 64 0.0033
649 CARDIAC FAILURE CONGESTIVE 260 0.0033
650 MULTIPLE SCLEROSIS RELAPSE 221 0.0033
651 VERTIGO 193 0.0033
652 BLOOD ALKALINE PHOSPHATASE INCREASED 79 0.0032
653 ORAL DISCOMFORT 44 0.0032
654 RESPIRATORY RATE INCREASED 28 0.0032
655 HOSPITALISATION 474 0.0032
656 HYPOTENSION 628 0.0032
657 BRADYCARDIA 167 0.0032
658 MALAISE 1376 0.0032
659 THYROID DISORDER 48 0.0032
660 GALLBLADDER DISORDER 55 0.0032
661 RASH 1322 0.0032
662 SURGERY 175 0.0031
663 LYMPHADENOPATHY 108 0.0031
664 FLATULENCE 171 0.0031
665 SARS-COV-2 TEST POSITIVE 41 0.0031
666 TOOTH INFECTION 40 0.0031
667 BONE PAIN 177 0.0031
668 ANOREXIA 40 0.0031
669 PRODUCT DOSE OMISSION IN ERROR 77 0.0031
670 DRY EYE 142 0.0031
671 CEREBROVASCULAR ACCIDENT 513 0.0031
672 DEMENTIA 83 0.0031
673 THROMBOCYTOPENIA 334 0.0031
674 PRURITUS 1116 0.0031
675 DEEP VEIN THROMBOSIS 197 0.0031
676 BREAST PAIN 32 0.0031
677 NODULE 39 0.0031
678 PNEUMOTHORAX 47 0.0031
679 INITIAL INSOMNIA 30 0.0030
680 CHOLELITHIASIS 96 0.0030
681 LETHARGY 169 0.0030
682 HAEMATOCHEZIA 161 0.0030
683 SPINAL FRACTURE 58 0.0030
684 KNEE OPERATION 28 0.0030
685 INCREASED APPETITE 53 0.0030
686 MUSCULOSKELETAL DISCOMFORT 50 0.0030
687 HAEMATOMA 76 0.0030
688 POST PROCEDURAL HAEMORRHAGE 34 0.0030
689 SCAR 50 0.0030
690 RASH MACULO-PAPULAR 64 0.0030
691 BEDRIDDEN 38 0.0030
692 PALLOR 79 0.0030
693 THERAPEUTIC RESPONSE SHORTENED 88 0.0030
694 HYPONATRAEMIA 162 0.0030
695 DEPRESSED LEVEL OF CONSCIOUSNESS 112 0.0029
696 HYPERTHYROIDISM 41 0.0029
697 TREMOR 474 0.0029
698 HOT FLUSH 215 0.0029
699 VASCULITIS 33 0.0029
700 RENAL PAIN 30 0.0029
701 FLUSHING 290 0.0029
702 RASH MACULAR 98 0.0029
703 EPISTAXIS 212 0.0029
704 BLOOD COUNT ABNORMAL 44 0.0029
705 FEELING HOT 173 0.0029
706 NEPHROPATHY TOXIC 31 0.0029
707 FEELING COLD 78 0.0029
708 CORONARY ARTERY DISEASE 86 0.0029
709 ISCHAEMIC STROKE 50 0.0029
710 TOXIC EPIDERMAL NECROLYSIS 42 0.0029
711 SYNCOPE 279 0.0029
712 RETCHING 59 0.0029
713 PLASMA CELL MYELOMA 109 0.0029
714 SWOLLEN TONGUE 87 0.0029
715 VENTRICULAR EXTRASYSTOLES 29 0.0029
716 BODY TEMPERATURE INCREASED 57 0.0029
717 GENERALISED OEDEMA 34 0.0029
718 PULMONARY EMBOLISM 264 0.0028
719 CONJUNCTIVITIS 50 0.0028
720 FISTULA 31 0.0028
721 DYSKINESIA 111 0.0028
722 SINUS TACHYCARDIA 39 0.0028
723 PHOTOSENSITIVITY REACTION 45 0.0028
724 OFF LABEL USE 2352 0.0028
725 MALIGNANT NEOPLASM PROGRESSION 276 0.0028
726 UNRESPONSIVE TO STIMULI 70 0.0028
727 DRUG LEVEL DECREASED 28 0.0028
728 MEDICATION ERROR 150 0.0028
729 SKIN LESION 73 0.0028
730 NEUTROPENIA 365 0.0028
731 POST PROCEDURAL COMPLICATION 52 0.0028
732 INTERNATIONAL NORMALISED RATIO INCREASED 78 0.0028
733 DYSPHONIA 156 0.0027
734 TINNITUS 123 0.0027
735 ADVERSE DRUG REACTION 237 0.0027
736 SCAB 30 0.0027
737 CHILLS 312 0.0027
738 DEVICE RELATED INFECTION 41 0.0027
739 PRODUCT DOSE OMISSION ISSUE 725 0.0027
740 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 456 0.0027
741 SECRETION DISCHARGE 32 0.0027
742 CARDIOMYOPATHY 39 0.0027
743 HYPOKINESIA 38 0.0027
744 DISSEMINATED INTRAVASCULAR COAGULATION 37 0.0027
745 EYE PAIN 143 0.0027
746 PANCREATITIS ACUTE 58 0.0027
747 MALIGNANT MELANOMA 35 0.0027
748 LIP SWELLING 86 0.0027
749 PRODUCT AVAILABILITY ISSUE 57 0.0027
750 RHABDOMYOLYSIS 107 0.0026
751 COMPLICATION ASSOCIATED WITH DEVICE 34 0.0026
752 SPINAL PAIN 30 0.0026
753 THERAPEUTIC RESPONSE UNEXPECTED 116 0.0026
754 NEOPLASM PROGRESSION 91 0.0026
755 BODY HEIGHT DECREASED 28 0.0026
756 PULMONARY THROMBOSIS 28 0.0026
757 PULMONARY OEDEMA 115 0.0026
758 GINGIVAL BLEEDING 35 0.0026
759 SKIN DISCOLOURATION 117 0.0026
760 BACTERIAL INFECTION 47 0.0026
761 BLOOD TRIGLYCERIDES INCREASED 45 0.0026
762 SENSORY DISTURBANCE 41 0.0026
763 MIDDLE INSOMNIA 47 0.0026
764 SWELLING FACE 164 0.0026
765 CHROMATURIA 57 0.0026
766 TACHYCARDIA 223 0.0026
767 HYPERTENSIVE CRISIS 28 0.0026
768 BLOOD BILIRUBIN INCREASED 68 0.0026
769 MYALGIA 424 0.0026
770 HYPOGLYCAEMIA 121 0.0026
771 ABDOMINAL PAIN LOWER 63 0.0026
772 THROMBOSIS 201 0.0026
773 PULMONARY CONGESTION 33 0.0026
774 MYELODYSPLASTIC SYNDROME 36 0.0026
775 BONE DISORDER 46 0.0026
776 ERECTILE DYSFUNCTION 64 0.0026
777 NERVOUSNESS 131 0.0026
778 RESTLESSNESS 91 0.0025
779 AGEUSIA 62 0.0025
780 SPEECH DISORDER 130 0.0025
781 LOSS OF CONSCIOUSNESS 316 0.0025
782 LACTIC ACIDOSIS 78 0.0025
783 CHOLECYSTITIS 29 0.0025
784 CORONARY ARTERY OCCLUSION 34 0.0025
785 DYSSTASIA 72 0.0025
786 QUALITY OF LIFE DECREASED 33 0.0025
787 ECZEMA 117 0.0025
788 SKIN FISSURES 44 0.0025
789 RESPIRATORY FAILURE 176 0.0025
790 STAPHYLOCOCCAL INFECTION 80 0.0025
791 PRODUCT PRESCRIBING ERROR 56 0.0025
792 PAIN IN JAW 68 0.0025
793 DIALYSIS 34 0.0025
794 THROAT IRRITATION 106 0.0025
795 PSORIASIS 311 0.0024
796 UNDERDOSE 173 0.0024
797 PARAESTHESIA ORAL 34 0.0024
798 IMPAIRED WORK ABILITY 51 0.0024
799 PANCREATITIS 125 0.0024
800 ACUTE MYOCARDIAL INFARCTION 70 0.0024
801 MUSCULOSKELETAL DISORDER 45 0.0024
802 HALLUCINATION, AUDITORY 37 0.0024
803 ANKYLOSING SPONDYLITIS 30 0.0024
804 FEELING ABNORMAL 557 0.0024
805 THIRST 41 0.0024
806 THROAT TIGHTNESS 62 0.0024
807 SKIN DISORDER 76 0.0024
808 DRUG LEVEL INCREASED 38 0.0024
809 ERUCTATION 42 0.0024
810 CEREBRAL INFARCTION 56 0.0023
811 TOOTH LOSS 48 0.0023
812 ERYTHEMA 467 0.0023
813 ASCITES 67 0.0023
814 DISORIENTATION 90 0.0023
815 UNEVALUABLE EVENT 171 0.0023
816 BLOOD CREATINE PHOSPHOKINASE INCREASED 67 0.0023
817 HYPERHIDROSIS 289 0.0023
818 MUCOSAL INFLAMMATION 58 0.0023
819 INTENTIONAL SELF-INJURY 45 0.0023
820 UVEITIS 30 0.0023
821 COAGULOPATHY 37 0.0023
822 MENTAL IMPAIRMENT 54 0.0023
823 HAEMOPTYSIS 62 0.0023
824 SEPTIC SHOCK 95 0.0023
825 RESPIRATORY DISTRESS 61 0.0023
826 HYPERGLYCAEMIA 80 0.0023
827 RASH ERYTHEMATOUS 101 0.0023
828 PARALYSIS 31 0.0022
829 TACHYPNOEA 29 0.0022
830 METABOLIC ACIDOSIS 67 0.0022
831 HAIR TEXTURE ABNORMAL 29 0.0022
832 DIABETIC KETOACIDOSIS 51 0.0022
833 INCORRECT PRODUCT ADMINISTRATION DURATION 43 0.0022
834 THINKING ABNORMAL 40 0.0022
835 DERMATITIS ATOPIC 98 0.0022
836 GAMMA-GLUTAMYLTRANSFERASE INCREASED 47 0.0022
837 SEIZURE 238 0.0022
838 DIPLOPIA 54 0.0021
839 DRUG INTERACTION 331 0.0021
840 VISUAL IMPAIRMENT 254 0.0021
841 PRODUCT ADMINISTRATION ERROR 41 0.0021
842 ABNORMAL DREAMS 58 0.0021
843 AGRANULOCYTOSIS 38 0.0021
844 ANAPHYLACTIC REACTION 113 0.0021
845 MOOD ALTERED 56 0.0021
846 ARRHYTHMIA 98 0.0021
847 PANIC ATTACK 75 0.0021
848 PRODUCT QUALITY ISSUE 278 0.0021
849 FEELING JITTERY 39 0.0021
850 MUSCLE TWITCHING 47 0.0021
851 DIABETES MELLITUS 156 0.0021
852 DEVICE OCCLUSION 28 0.0021
853 EYE SWELLING 74 0.0021
854 FACE OEDEMA 34 0.0021
855 LACRIMATION INCREASED 59 0.0021
856 DISTURBANCE IN ATTENTION 108 0.0020
857 GENERALISED TONIC-CLONIC SEIZURE 32 0.0020
858 ACTIVITIES OF DAILY LIVING IMPAIRED 40 0.0020
859 DRY SKIN 254 0.0020
860 AGITATION 144 0.0020
861 ACCIDENTAL OVERDOSE 71 0.0020
862 CARDIAC FAILURE 156 0.0020
863 VENTRICULAR TACHYCARDIA 32 0.0020
864 EYE DISORDER 63 0.0020
865 CYTOKINE RELEASE SYNDROME 35 0.0020
866 PULMONARY ARTERIAL HYPERTENSION 28 0.0020
867 MENTAL DISORDER 83 0.0020
868 LIVER FUNCTION TEST ABNORMAL 56 0.0020
869 HEPATIC FUNCTION ABNORMAL 70 0.0020
870 EXPOSURE DURING PREGNANCY 118 0.0020
871 BONE MARROW FAILURE 39 0.0019
872 SEDATION 49 0.0019
873 JAUNDICE 51 0.0019
874 RASH PAPULAR 42 0.0019
875 CARDIO-RESPIRATORY ARREST 79 0.0019
876 PREGNANCY 38 0.0019
877 CHOKING 36 0.0019
878 HAEMORRHAGE INTRACRANIAL 28 0.0019
879 SHOCK 42 0.0019
880 APATHY 27 0.0019
881 BONE DENSITY DECREASED 59 0.0019
882 CRYING 67 0.0019
883 HAEMORRHAGE 190 0.0019
884 NEUROTOXICITY 31 0.0019
885 ANGIOEDEMA 79 0.0018
886 PARANOIA 31 0.0018
887 METASTASES TO BONE 29 0.0018
888 BLOOD GLUCOSE DECREASED 85 0.0018
889 PROTEINURIA 33 0.0018
890 THERAPY INTERRUPTED 116 0.0018
891 ACUTE MYELOID LEUKAEMIA 27 0.0018
892 DISEASE PROGRESSION 204 0.0018
893 EYE PRURITUS 56 0.0018
894 CHOLESTASIS 33 0.0018
895 EMOTIONAL DISORDER 54 0.0018
896 ABNORMAL BEHAVIOUR 69 0.0018
897 MYOCARDIAL INFARCTION 301 0.0017
898 ACUTE RESPIRATORY DISTRESS SYNDROME 30 0.0017
899 NIGHTMARE 59 0.0017
900 CIRCULATORY COLLAPSE 29 0.0017
901 DYSGEUSIA 127 0.0017
902 HYPOACUSIS 72 0.0017
903 ALTERED STATE OF CONSCIOUSNESS 36 0.0017
904 CEREBRAL HAEMORRHAGE 60 0.0017
905 CARDIAC ARREST 139 0.0017
906 DISEASE RECURRENCE 80 0.0017
907 RASH GENERALISED 43 0.0017
908 INJECTION SITE WARMTH 33 0.0016
909 PROCEDURAL PAIN 44 0.0016
910 EMOTIONAL DISTRESS 195 0.0016
911 DRUG INEFFECTIVE 2094 0.0016
912 GASTRIC DISORDER 56 0.0016
913 INCORRECT DRUG ADMINISTRATION DURATION 45 0.0016
914 EXPOSURE VIA SKIN CONTACT 30 0.0016
915 COLITIS ULCERATIVE 68 0.0016
916 THERAPY CESSATION 78 0.0016
917 BLINDNESS 62 0.0016
918 NEEDLE ISSUE 43 0.0016
919 SUICIDAL IDEATION 140 0.0016
920 AGGRESSION 76 0.0016
921 INTENTIONAL PRODUCT MISUSE 130 0.0015
922 ANGER 51 0.0015
923 LUNG NEOPLASM MALIGNANT 62 0.0015
924 PRODUCT DOSE OMISSION 100 0.0015
925 BLOOD GLUCOSE INCREASED 282 0.0015
926 INCORRECT DOSE ADMINISTERED 328 0.0015
927 IRRITABILITY 87 0.0015
928 INJECTION SITE RASH 43 0.0015
929 PSYCHOTIC DISORDER 42 0.0015
930 DRUG PRESCRIBING ERROR 28 0.0015
931 PAIN OF SKIN 38 0.0014
932 OSTEONECROSIS OF JAW 35 0.0014
933 ABASIA 35 0.0014
934 ANAPHYLACTIC SHOCK 35 0.0014
935 NERVOUS SYSTEM DISORDER 43 0.0014
936 TRANSAMINASES INCREASED 30 0.0014
937 MULTIPLE ORGAN DYSFUNCTION SYNDROME 37 0.0014
938 DEATH 1138 0.0014
939 STEVENS-JOHNSON SYNDROME 29 0.0013
940 ABORTION SPONTANEOUS 52 0.0013
941 RESPIRATORY ARREST 36 0.0013
942 OSTEONECROSIS 43 0.0013
943 VAGINAL HAEMORRHAGE 55 0.0013
944 HEPATIC FAILURE 38 0.0013
945 OCULAR HYPERAEMIA 58 0.0013
946 MYELOSUPPRESSION 40 0.0013
947 INJECTION SITE REACTION 83 0.0012
948 ELECTROCARDIOGRAM QT PROLONGED 43 0.0012
949 EYE IRRITATION 65 0.0012
950 MOOD SWINGS 37 0.0012
951 NEOPLASM MALIGNANT 77 0.0012
952 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 84 0.0012
953 TOXICITY TO VARIOUS AGENTS 189 0.0012
954 INJECTION SITE MASS 41 0.0011
955 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 63 0.0011
956 SUICIDE ATTEMPT 66 0.0011
957 GYNAECOMASTIA 34 0.0011
958 INJECTION SITE PAIN 319 0.0011
959 CONVULSION 62 0.0011
960 INJECTION SITE BRUISING 81 0.0011
961 INJECTION SITE PRURITUS 68 0.0011
962 INJECTION SITE HAEMORRHAGE 80 0.0010
963 INJECTION SITE SWELLING 74 0.0010
964 FOETAL EXPOSURE DURING PREGNANCY 78 0.0010
965 DRUG EFFECT DECREASED 53 0.0010
966 DEVICE ISSUE 82 0.0010
967 INJECTION SITE ERYTHEMA 116 0.0010
968 NO ADVERSE EVENT 166 0.0010
969 EXTRA DOSE ADMINISTERED 37 0.0010
970 PRODUCT SUBSTITUTION ISSUE 54 0.0010
971 VISUAL ACUITY REDUCED 31 0.0009
972 INTENTIONAL OVERDOSE 56 0.0009
973 ACNE 66 0.0009
974 OVERDOSE 186 0.0009
975 DEVICE DISLOCATION 37 0.0009
976 DRUG DOSE OMISSION 144 0.0009
977 EXPIRED PRODUCT ADMINISTERED 28 0.0009
978 PROSTATE CANCER 69 0.0009
979 SKIN IRRITATION 37 0.0008
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 152 0.0008
981 COMPLETED SUICIDE 59 0.0007
982 WITHDRAWAL SYNDROME 29 0.0007
983 DEVICE MALFUNCTION 38 0.0006
984 BREAST CANCER 55 0.0006
985 SKIN BURNING SENSATION 39 0.0006
986 PRODUCT STORAGE ERROR 41 0.0005
987 ACCIDENTAL EXPOSURE TO PRODUCT 45 0.0005
988 DRUG WITHDRAWAL SYNDROME 40 0.0005
989 DRUG ABUSE 36 0.0004
990 DRUG DEPENDENCE 52 0.0003